1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    






































































































































































    The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review | American Journal of Neuroradiology  
    

















    





























    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Review ArticleReview Articles

  
      
Open Access

  
      
The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review
  
    	
C. Odenthal and A. Coulthard

  
    	
American Journal of Neuroradiology March 2015,  36 (3) 425-431; DOI: https://doi.org/10.3174/ajnr.A3954 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
REFERENCES
  1. 1.↵


    1. 

    2. Miller  DH, 
    3. Chard  DT, 
    4. Ciccarelli  O
    . Clinically isolated syndromes. Lancet Neurol 2012;11:157–69
    CrossRefPubMedWeb of Science
  2. 2.↵


    1. 

    2. Miller  DH, 
    3. Weinshenker  BG, 
    4. Filippi  M, et al
    . Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14:1157–74
    Abstract/FREE Full Text
  3. 3.↵


    1. 

    2. Tozer  DJ, 
    3. Marongiu  G, 
    4. Swanton  JK, et al
    . Texture analysis of magnetization transfer maps from patients with clinically isolated syndrome and multiple sclerosis. J Magn Reson Imaging 2009;30:506–13
    CrossRefPubMedWeb of Science
  4. 4.↵


    1. 

    2. Summers  M, 
    3. Swanton  J, 
    4. Fernando  K, et al
    . Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease. J Neurol Neurosurg Psychiatry 2008;79:955–58
    Abstract/FREE Full Text
  5. 5.↵


    1. 

    2. Patrucco  L, 
    3. Rojas  JI, 
    4. Miguez  JS, et al
    . Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes. Mult Scler 2013;19:1297–301
    Abstract/FREE Full Text
  6. 6.↵


    1. 

    2. Brex  PA, 
    3. Ciccarelli  O, 
    4. O'Riordan  JI, et al
    . A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158–64
    CrossRefPubMedWeb of Science
  7. 7.↵


    1. 

    2. Fisniku  LK, 
    3. Brex  PA, 
    4. Altmann  DR, et al
    . Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008;131:808–17
    Abstract/FREE Full Text
  8. 8.↵


    1. 

    2. Brex  PA, 
    3. O'Riordan  JI, 
    4. Miszkiel  KA, et al
    . Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology 1999;53:1184–90
    CrossRef
  9. 9.↵


    1. 

    2. Tintoré  M, 
    3. Rovira  A, 
    4. Río  J, et al
    . Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006;67:968–72
    CrossRef
  10. 10.↵


    1. 

    2. Alroughani  R, 
    3. Al Hashel  J, 
    4. Lamdhade  S, et al
    . Predictors of conversion to multiple sclerosis in patients with clinical isolated syndrome using the 2010 revised McDonald criteria. ISRN Neurol 2012;2012:792192
    PubMed
  11. 11.↵


    1. 

    2. Dalton  CM, 
    3. Brex  PA, 
    4. Jenkins  R, et al
    . Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;73:141–47
    Abstract/FREE Full Text
  12. 12.↵


    1. 

    2. Moraal  B, 
    3. Pohl  C, 
    4. Uitdehaag  BM, et al
    . Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Arch Neurol 2009;66:1345–52
    CrossRefPubMedWeb of Science
  13. 13.↵


    1. 

    2. Brex  PA, 
    3. Miszkiel  KA, 
    4. O'Riordan  JI, et al
    . Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J Neurol Neurosurg Psychiatry 2001;70:390–93
    Abstract/FREE Full Text
  14. 14.↵


    1. 

    2. Pestalozza  IF, 
    3. Pozzilli  C, 
    4. Di Legge  S, et al
    . Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome. Mult Scler 2005;11:390–94
    Abstract/FREE Full Text
  15. 15.↵


    1. 

    2. Dalton  CM, 
    3. Brex  PA, 
    4. Miszkiel  KA, et al
    . Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002;52:47–53
    CrossRefPubMedWeb of Science
  16. 16.↵


    1. 

    2. Zivadinov  R, 
    3. Havrdová  E, 
    4. Bergsland  N, et al
    . Thalamic atrophy is associated with development of clinically definite multiple sclerosis. Radiology 2013;268:831–41
    CrossRefPubMed
  17. 17.↵


    1. 

    2. Brex  PA, 
    3. Leary  SM, 
    4. Plant  GT, et al
    . Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. AJNR Am J Neuroradiol 2001;22:947–51
    Abstract/FREE Full Text
  18. 18.↵


    1. 

    2. Zhang  WY, 
    3. Hou  YL
    . Prognostic value of magnetic resonance imaging in patients with clinically isolated syndrome conversion to multiple sclerosis: a meta-analysis. Neurol India 2013;61:231–38
    CrossRefPubMed
  19. 19.↵


    Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo group. Mult Scler 2002;8:405–09
    Abstract/FREE Full Text
  20. 20.↵


    CHAMPS Study Group. MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology 2002;59:998–1005
    CrossRef
  21. 21.↵


    Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial. Controlled high-risk subjects Avonex multiple sclerosis prevention study. Mult Scler 2002;8:330–38
    Abstract/FREE Full Text
  22. 22.↵


    1. 

    2. Kalincik  T, 
    3. Vaneckova  M, 
    4. Tyblova  M, et al
    . Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study. PloS One 2012;7:e50101
    CrossRefPubMedWeb of Science
  23. 23.↵


    1. 

    2. Polman  C, 
    3. Kappos  L, 
    4. Freedman  MS, et al
    . Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. J Neurol 2008;255:480–87
    CrossRefPubMedWeb of Science
  24. 24.↵


    1. 

    2. Rovira  A, 
    3. Swanton  J, 
    4. Tintore  M, et al
    . A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 2009;66:587–92
    CrossRefPubMedWeb of Science
  25. 25.↵


    1. 

    2. Nielsen  JM, 
    3. Pohl  C, 
    4. Polman  CH, et al
    . MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome. BMC Neurol 2009;9:19
    CrossRefPubMed
  26. 26.↵


    1. 

    2. Kurtzke  JF
    . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52
    CrossRefPubMed
  27. 27.↵


    1. 

    2. Whitaker  JN, 
    3. McFarland  HF, 
    4. Rudge  P, et al
    . Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler 1995;1:37–47
    Abstract/FREE Full Text
  28. 28.↵


    1. 

    2. Rudick  R, 
    3. Antel  J, 
    4. Confavreux  C, et al
    . Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996;40:469–79
    CrossRefPubMedWeb of Science
  29. 29.↵


    1. 

    2. Di Filippo  M, 
    3. Anderson  VM, 
    4. Altmann  DR, et al
    . Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2010;81:204–08
    Abstract/FREE Full Text
  30. 30.↵


    1. 

    2. Kincses  ZT, 
    3. Ropele  S, 
    4. Jenkinson  M, et al
    . Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler 2011;17:681–89
    Abstract/FREE Full Text
  31. 31.↵


    1. 

    2. Ceccarelli  A, 
    3. Rocca  MA, 
    4. Pagani  E, et al
    . A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. NeuroImage 2008;42:315–22
    CrossRefPubMedWeb of Science
  32. 32.↵


    1. 

    2. Brex  PA, 
    3. Gomez-Anson  B, 
    4. Parker  GJ, et al
    . Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Sci 1999;166:16–22
    CrossRefPubMedWeb of Science
  33. 33.↵


    1. 

    2. Jafari  N, 
    3. Kreft  KL, 
    4. Flach  HZ, et al
    . Callosal lesion predicts future attacks after clinically isolated syndrome. Neurology 2009;73:1837–41
    CrossRef
  34. 34.↵


    1. 

    2. Tintore  M, 
    3. Rovira  A, 
    4. Arrambide  G, et al
    . Brainstem lesions in clinically isolated syndromes. Neurology 2010;75:1933–38
    CrossRef
  35. 35.↵


    1. 

    2. Minneboo  A, 
    3. Barkhof  F, 
    4. Polman  CH, et al
    . Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004;61:217–21
    CrossRefPubMedWeb of Science
  36. 36.↵


    1. 

    2. Frischer  JM, 
    3. Bramow  S, 
    4. Dal-Bianco  A, et al
    . The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009;132:1175–89
    Abstract/FREE Full Text
  37. 37.↵


    1. 

    2. Ashburner  J, 
    3. Friston  KJ
    . Unified segmentation. NeuroImage 2005;26:839–51
    CrossRefPubMedWeb of Science
  38. 38.↵


    1. 

    2. Dale  AM, 
    3. Fischl  B, 
    4. Sereno  MI
    . Cortical surface-based analysis—I. Segmentation and surface reconstruction. NeuroImage 1999;9:179–94
    CrossRefPubMedWeb of Science
  39. 39.↵


    1. 

    2. Dale  AM, 
    3. Sereno  MI
    . Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction–a linear approach. J Cogn Neurosci 1993;5:162–76
    CrossRefPubMedWeb of Science
  40. 40.↵


    1. 

    2. Smith  SM, 
    3. Jenkinson  M, 
    4. Woolrich  MW, et al
    . Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004;23 Suppl 1:S208–19
    CrossRefPubMedWeb of Science
  41. 41.↵


    1. 

    2. Smith  SM, 
    3. Zhang  Y, 
    4. Jenkinson  M, et al
    . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002;17:479–89
    CrossRefPubMedWeb of Science
  42. 42.↵


    1. 

    2. Hagman  S, 
    3. Raunio  M, 
    4. Rossi  M, et al
    . Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: prospective clinical and MRI follow-up study. J Neuroimmunol 2011;234:141–47
    CrossRefPubMedWeb of Science
  43. 43.↵


    1. 

    2. Teunissen  CE, 
    3. Iacobaeus  E, 
    4. Khademi  M, et al
    . Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 2009;72:1322–29
    CrossRef
  44. 44.↵


    1. 

    2. Roosendaal  SD, 
    3. Bendfeldt  K, 
    4. Vrenken  H, et al
    . Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler 2011;17:1098–106
    Abstract/FREE Full Text
  45. 45.↵


    1. 

    2. Bergsland  N, 
    3. Horakova  D, 
    4. Dwyer  MG, et al
    . Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2012;33:1573–78
    Abstract/FREE Full Text
  46. 46.↵


    1. 

    2. Rocca  MA, 
    3. Agosta  F, 
    4. Sormani  MP, et al
    . A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol 2008;255:683–91
    CrossRefPubMedWeb of Science
  47. 47.↵


    1. 

    2. Hagemeier  J, 
    3. Weinstock-Guttman  B, 
    4. Bergsland  N, et al
    . Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 2012;33:1596–601
    Abstract/FREE Full Text
  48. 48.↵


    1. 

    2. Tavazzi  E, 
    3. Dwyer  MG, 
    4. Weinstock-Guttman  B, et al
    . Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. NeuroImage 2007;36:746–54
    CrossRefPubMedWeb of Science
  49. 49.↵


    1. 

    2. Iannucci  G, 
    3. Tortorella  C, 
    4. Rovaris  M, et al
    . Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. AJNR Am J Neuroradiol 2000;21:1034–38
    Abstract/FREE Full Text
  50. 50.↵


    1. 

    2. Calabrese  M, 
    3. Rinaldi  F, 
    4. Mattisi  I, et al
    . The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology 2011;77:257–63
    CrossRef
  51. 51.↵


    1. 

    2. Paolillo  A, 
    3. Piattella  MC, 
    4. Pantano  P, et al
    . The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA. J Neurol 2004;251:432–39
    CrossRefPubMedWeb of Science
  52. 52.↵


    1. 

    2. Henry  RG, 
    3. Shieh  M, 
    4. Okuda  DT, et al
    . Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008;79:1236–44
    Abstract/FREE Full Text
  53. 53.↵


    1. 

    2. Traboulsee  A, 
    3. Dehmeshki  J, 
    4. Brex  PA, et al
    . Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology 2002;59:126–28
    CrossRef
  54. 54.↵


    1. 

    2. Rudick  RA, 
    3. Lee  JC, 
    4. Nakamura  K, et al
    . Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 2009;282:106–11
    CrossRefPubMed
  55. 55.↵


    1. 

    2. Sbardella  E, 
    3. Tomassini  V, 
    4. Stromillo  ML, et al
    . Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2011;17:1432–40
    Abstract/FREE Full Text
  56. 56.↵


    1. 

    2. Raz  E, 
    3. Cercignani  M, 
    4. Sbardella  E, et al
    . Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology 2010;254:227–34
    CrossRefPubMedWeb of Science
  57. 57.↵


    1. 

    2. Ceccarelli  A, 
    3. Rocca  MA, 
    4. Perego  E, et al
    . Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis. Mult Scler 2011;17:702–07
    Abstract/FREE Full Text
  58. 58.↵


    1. 

    2. Derakhshan  M, 
    3. Caramanos  Z, 
    4. Giacomini  PS, et al
    . Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. NeuroImage 2010;52:1261–67
    CrossRefPubMedWeb of Science
  59. 59.↵


    1. 

    2. Battaglini  M, 
    3. Jenkinson  M, 
    4. De Stefano  N
    . Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 2012;33:2062–71
    CrossRefPubMedWeb of Science
  60. 60.↵


    1. 

    2. Rovaris  M, 
    3. Judica  E, 
    4. Ceccarelli  A, et al
    . A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol 2008;255:1209–14
    CrossRefPubMedWeb of Science
  61. 61.↵


    1. 

    2. De Stefano  N, 
    3. Giorgio  A, 
    4. Battaglini  M, et al
    . Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 2010;74:1868–76
    CrossRef
  62. 62.↵


    1. 

    2. Audoin  B, 
    3. Ibarrola  D, 
    4. Malikova  I, et al
    . Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis–a 2-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler 2007;13:41–51
    Abstract/FREE Full Text
  63. 63.↵


    1. 

    2. Beaulieu  C, 
    3. Allen  PS
    . Determinants of anisotropic water diffusion in nerves. Magn Reson Med 1994;31:394–400
    CrossRefPubMedWeb of Science
  64. 64.↵


    1. 

    2. Yu  CS, 
    3. Lin  FC, 
    4. Liu  Y, et al
    . Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis. Eur J Radiol 2008;68:328–34
    CrossRefPubMedWeb of Science
  65. 65.↵


    1. 

    2. Caramia  F, 
    3. Pantano  P, 
    4. Di Legge  S, et al
    . A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging 2002;20:383–88
    CrossRefPubMedWeb of Science
  66. 66.↵


    1. 

    2. Pagani  E, 
    3. Filippi  M, 
    4. Rocca  MA, et al
    . A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis. NeuroImage 2005;26:258–65
    CrossRefPubMedWeb of Science
  67. 67.↵


    1. 

    2. Preziosa  P, 
    3. Rocca  MA, 
    4. Mesaros  S, et al
    . Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. Radiology 2011;260:541–50
    CrossRefPubMedWeb of Science
  68. 68.↵


    1. 

    2. Smith  SM, 
    3. Jenkinson  M, 
    4. Johansen-Berg  H, et al
    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 2006;31:1487–505
    CrossRefPubMedWeb of Science
  69. 69.↵


    1. 

    2. Raz  E, 
    3. Cercignani  M, 
    4. Sbardella  E, et al
    . Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology 2010;257:448–54
    CrossRefPubMedWeb of Science
  70. 70.↵


    1. 

    2. Pike  GB
    . Pulsed magnetization transfer contrast in gradient echo imaging: a two-pool analytic description of signal response. Magn Reson Med 1996;36:95–103
    CrossRefPubMedWeb of Science
  71. 71.↵


    1. 

    2. Fernando  KT, 
    3. Tozer  DJ, 
    4. Miszkiel  KA, et al
    . Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005;128:2911–25
    Abstract/FREE Full Text
  72. 72.↵


    1. 

    2. Khalil  M, 
    3. Enzinger  C, 
    4. Langkammer  C, et al
    . Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler 2011;17:173–80
    Abstract/FREE Full Text
  73. 73.↵


    1. 

    2. Gallo  A, 
    3. Rovaris  M, 
    4. Benedetti  B, et al
    . A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. J Neurol 2007;254:78–83
    CrossRefPubMedWeb of Science
  74. 74.↵


    1. 

    2. Wattjes  MP, 
    3. Harzheim  M, 
    4. Lutterbey  GG, et al
    . Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy. AJNR Am J Neuroradiol 2007;28:1517–22
    Abstract/FREE Full Text
  75. 75.↵


    1. 

    2. Fernando  KT, 
    3. McLean  MA, 
    4. Chard  DT, et al
    . Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004;127:1361–69
    Abstract/FREE Full Text
  76. 76.↵


    1. 

    2. Wattjes  MP, 
    3. Harzheim  M, 
    4. Lutterbey  GG, et al
    . Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology 2008;50:123–29
    CrossRefPubMedWeb of Science
  77. 77.↵


    1. 

    2. Pantano  P, 
    3. Iannetti  GD, 
    4. Caramia  F, et al
    . Cortical motor reorganization after a single clinical attack of multiple sclerosis. Brain 2002;125:1607–15
    Abstract/FREE Full Text
  78. 78.↵


    1. 

    2. Rocca  MA, 
    3. Colombo  B, 
    4. Falini  A, et al
    . Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol 2005;4:618–26
    CrossRefPubMedWeb of Science
  79. 79.↵


    1. 

    2. Filippi  M, 
    3. Rocca  MA, 
    4. Mezzapesa  DM, et al
    . Simple and complex movement-associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Hum Brain Mapp 2004;21:108–17
    CrossRefPubMedWeb of Science
  80. 80.↵


    1. 

    2. Rocca  MA, 
    3. Mezzapesa  DM, 
    4. Ghezzi  A, et al
    . A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. AJNR Am J Neuroradiol 2005;26:1136–39
    Abstract/FREE Full Text
  81. 81.↵


    1. 

    2. Audoin  B, 
    3. Reuter  F, 
    4. Duong  MV, et al
    . Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study. Mult Scler 2008;14:786–92
    Abstract/FREE Full Text
  82. 82.↵


    1. 

    2. Rocca  MA, 
    3. Absinta  M, 
    4. Moiola  L, et al
    . Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. Radiology 2010;254:541–50
    CrossRefPubMedWeb of Science
  83. 83.↵


    1. 

    2. Liu  Y, 
    3. Duan  Y, 
    4. Liang  P, et al
    . Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI. Acta Radiol 2012;53:1073–78
    Abstract/FREE Full Text
  84. 84.↵


    1. 

    2. Liu  Y, 
    3. Liang  P, 
    4. Duan  Y, et al
    . Brain plasticity in relapsing-remitting multiple sclerosis: evidence from resting-state fMRI. J Neurol Sci 2011;304:127–31
    CrossRefPubMed
  85. 85.↵


    1. 

    2. Varga  AW, 
    3. Johnson  G, 
    4. Babb  JS, et al
    . White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci 2009;282:28–33
    CrossRefPubMed
  86. 86.↵


    1. 

    2. Ge  Y, 
    3. Jensen  JH, 
    4. Lu  H, et al
    . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639–44
    Abstract/FREE Full Text
  87. 87.↵


    1. 

    2. Ceccarelli  A, 
    3. Rocca  MA, 
    4. Neema  M, et al
    . Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult Scler 2010;16:39–44
    Abstract/FREE Full Text
  88. 88.↵


    1. 

    2. Khalil  M, 
    3. Enzinger  C, 
    4. Langkammer  C, et al
    . Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009;15:1048–54
    Abstract/FREE Full Text
  89. 89.↵


    1. 

    2. Khalil  M, 
    3. Langkammer  C, 
    4. Ropele  S, et al
    . Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77:1691–97
    CrossRef
  90. 90.↵


    1. 

    2. Langkammer  C, 
    3. Liu  T, 
    4. Khalil  M, et al
    . Quantitative susceptibility mapping in multiple sclerosis. Radiology 2013;267:551–59
    CrossRefPubMedWeb of Science
  91. 91.↵


    1. 

    2. Quinn  MP, 
    3. Gati  JS, 
    4. Klassen  ML, et al
    . Increased deep grey matter iron is present in clinically isolated syndromes. Mult Scler 2014;3:194–202
  92. 92.↵


    1. 

    2. Meca-Lallana  JE, 
    3. Hernandez-Clares  R, 
    4. Leon-Hernandez  A, et al
    . Plasma exchange for steroid-refractory relapses in multiple sclerosis: an observational, MRI pilot study. Clin Ther 2013;35:474–85
    CrossRefPubMed
  93. 93.↵


    1. 

    2. Kinkel  RP, 
    3. Dontchev  M, 
    4. Kollman  C, et al
    . Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the controlled high-risk Avonex multiple sclerosis prevention study in ongoing neurological surveillance. Arch Neurol 2012;69:183–90
    CrossRefPubMedWeb of Science
  94. 94.↵


    1. 

    2. Kappos  L, 
    3. Polman  CH, 
    4. Freedman  MS, et al
    . Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006;67:1242–49
    CrossRef
  95. 95.↵


    1. 

    2. Barkhof  F, 
    3. Polman  CH, 
    4. Radue  EW, et al
    . Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results. Arch Neurol 2007;64:1292–98
    CrossRefPubMedWeb of Science
  96. 96.↵


    1. 

    2. Kinkel  RP, 
    3. Simon  JH, 
    4. Baron  B
    . Bimonthly cranial MRI activity following an isolated monosymptomatic demyelinating syndrome: potential outcome measures for future multiple sclerosis ‘prevention’ trials. Mult Scler 1999;5:307–12
    Abstract/FREE Full Text
  97. 97.↵


    1. 

    2. Deoni  SC, 
    3. Rutt  BK, 
    4. Jones  DK
    . Investigating exchange and multicomponent relaxation in fully balanced steady-state free precession imaging. J Magn Reson Imaging 2008;27:1421–29
    CrossRefPubMed
  98. 98.↵


    1. 

    2. Kitzler  HH, 
    3. Su  J, 
    4. Zeineh  M, et al
    . Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI. NeuroImage 2012;59:2670–77
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review
  
    	
C. Odenthal, A. Coulthard

  
    	
 American Journal of Neuroradiology Mar 2015, 36 (3) 425-431; DOI: 10.3174/ajnr.A3954 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement